Dysregulation of Peripheral Blood Mononuclear Cells and Immune-Related Proteins during the Early Post-Operative Immune Response in Ovarian Cancer Patients.
Jonas UleviciusAldona JasukaitieneArenida BartkevicieneZilvinas DambrauskasAntanas GulbinasDaiva UrbonieneSaulius PaskauskasPublished in: Cancers (2023)
Surgical treatment is a cornerstone of ovarian cancer (OC) therapy and exerts a substantial influence on the immune system. Immune responses also play a pivotal and intricate role in OC progression. The aim of this study was to investigate the dynamics of immune-related protein expression and the activity of peripheral blood mononuclear cells (PBMCs) in OC patients, both before surgery and during the early postoperative phase. The study cohort comprised 23 OC patients and 20 non-cancer controls. A comprehensive analysis of PBMCs revealed significant pre-operative downregulation in the mRNA expression of multiple immune-related proteins, including interleukins, PD-1, PD-L1, and HO-1. This was followed by further dysregulation during the first 5 post-operative days. Although most serum interleukin concentrations showed only minor changes, a distinct increase in IL-6 and HO-1 levels was observed post-operatively. Reduced metabolic and phagocytic activity and increased production of reactive oxygen species (ROS) were observed on day 1 post-surgery. These findings suggest a shift towards immune tolerance during the early post-operative phase of OC, potentially creating a window for treatment. Further research into post-operative PBMC activity could lead to the development of new or improved treatment strategies for OC.
Keyphrases
- immune response
- end stage renal disease
- ejection fraction
- chronic kidney disease
- reactive oxygen species
- peritoneal dialysis
- minimally invasive
- prognostic factors
- stem cells
- squamous cell carcinoma
- toll like receptor
- cell death
- oxidative stress
- signaling pathway
- mesenchymal stem cells
- inflammatory response
- single cell